Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?

被引：8
|
作者：
Hanna, G. G. [1 ]
Illidge, T. [2 ]
机构：
[1] Queens Univ Belfast, Ctr Canc Res & Cell Biol, 95 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland
[2] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Canc Sci, Manchester Canc Res Ctr,Christie Hosp, Manchester, Lancs, England
来源：
CLINICAL ONCOLOGY | 2016年 / 28卷 / 11期
关键词：
Checkpoint inhibition; immunotherapy; NSCLC; radiotherapy; IMMUNE-RELATED RESPONSE; TUMOR MICROENVIRONMENT; IONIZING-RADIATION; SOLID TUMORS; MELANOMA; MODULATION; MECHANISMS; IPILIMUMAB; RESISTANCE; DOCETAXEL;
D O I：
10.1016/j.clon.2016.07.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The goal of re-programming the host immune system to target malignancy with durable anti-tumour clinical responses has been speculated for decades. In the last decade such speculation has been transformed into reality with unprecedented and durable responses to immune checkpoint inhibitors seen in solid tumours. This mini-review considers the mechanism of action of immune modulating agents and the potential for combination with radiotherapy in the treatment of non-small cell lung cancer. (C) 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：726 / 731
页数：6
相关论文
共 50 条
  • [1] Prior or concurrent radiotherapy and nivolumab immunotherapy in non-small cell lung cancer
    Ratnayake, Gishan
    Shanker, Mihir
    Roberts, Kate
    Mason, Robert
    Hughes, Brett G. M.
    Lwin, Zarnie
    Jain, Vikram
    O'Byrne, Kenneth
    Lehman, Margot
    Chua, Benjamin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (01) : 56 - 62
  • [2] New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer
    Luna, Javier
    Zafra, Juan
    Areses Manrique, Ma Carmen
    Rodriguez, Aurora
    Sotoca, Amalia
    Firvida, Jose Luis
    Chicas-Sett, Rodolfo
    Mielgo, Xabier
    Reyes, Juan Carlos Trujillo
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (11): : 983 - 999
  • [3] Immunotherapy combinations emerging in non-small-cell lung cancer
    Chao, Yvonne L.
    Pecot, Chad V.
    IMMUNOTHERAPY, 2018, 10 (08) : 627 - 629
  • [4] Combined treatment of non-small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
    Shang, Shijie
    Liu, Jie
    Verma, Vivek
    Wu, Meng
    Welsh, James
    Yu, Jinming
    Chen, Dawei
    CANCER COMMUNICATIONS, 2021, 41 (11) : 1086 - 1099
  • [5] Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives
    Cella, Eugenia
    Zullo, Lodovica
    Marconi, Silvia
    Rossi, Giovanni
    Coco, Simona
    Dellepiane, Chiara
    Alama, Angela
    Rozeboom, Leslie
    Bennicelli, Elisa
    Parisi, Francesca
    Sacco, Gianluca
    Barletta, Giulia
    Zinoli, Linda
    Tagliamento, Marco
    Pronzato, Paolo
    Genova, Carlo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (10) : 1259 - 1273
  • [6] Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non-Small Cell Lung Cancer
    Anagnostou, Valsamo K.
    Brahmer, Julie R.
    CLINICAL CANCER RESEARCH, 2015, 21 (05) : 976 - 984
  • [7] Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Huang, Joy
    Reckamp, Karen L.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 400 - 408
  • [8] Updates on immunotherapy in non-small cell lung cancer
    Shimanovsky, Alexei
    Dasanu, Constantin A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (04) : 411 - 418
  • [9] Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer
    Adderley, H.
    Blackhall, F. H.
    Lindsay, C. R.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (03) : 589 - 595
  • [10] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
12345